Opening Hours:Monday To Saturday - 8am To 9pm


Our Promise


By joining the NAPM your company benefits from a collective, unified industry voice that ensures greater access and local impact to key industry stakeholders

Key Areas where the NAPM is making a difference:


The NAPM is a consensus-driven association that seeks to build a common industry view. Proactive and constructive engagement with regulatory, government and policy stakeholders.

Working towards creating an environment conducive to the growth and development of the pharmaceutical industry in South Africa, and beyond.

Ensuring that our efforts at policy and strategic level proactively contributes to and informs healthcare policies and reforms.

Maximizing industry knowledge and relationships to create positive change within the healthcare environment.

To ensure equitable pricing to ensure the viability of the industry while also providing a cost effective healthcare system.

Policy Advice

Providing leadership and insight on legislative, scientific and technical, pricing, trade and tender issues.

Offering a better understanding of the increased regulatory environment in South Africa and easing the and legislation burden for our members.

Keeping members updated on the constantly evolving requirements within South Africa’s market through intense scrutiny by policy makers and regulatory authorities.

Monitoring of industry developments thereby ensuring industry input and response on all relevant generic matters.

Collectively working with other lobbying associations on joint issues to maximise exposure, bargaining presence, stakeholder engagement contacts and impact.

Keeping members informed through proper reporting channels on the activities of the various sub- committees.

Providing an intellectual property framework that rewards research and innovation while still allowing reasonable access for generic companies to commercialise these inventions after patent expiry.

Improving Efficiencies

At the NAPM we are working with government to find ways to help improve efficiencies within South Africa’s regulatory and registration bodies.

Promoting the use of generics, by increasing market share in South Africa and by encouraging the increased registration of generic medicines.

Helping to shape best practices, effective public policy and delivery and core service values for the industry.

The NAPM ensuring that its members are able to operate in a fair and equitable environment

The NAPM to challenge government and regulatory bodies to ensure a fair playing field and regulations that benefit its members

Collective Local Representation

The NAPM represents interests of a diverse group of generic companies including importers and local manufactures, as well as multinational with a generics platform.

Creating an environment conducive to future growth, competitiveness & sustainability of the industry (increasing market share)

The NAPM is the preferred communication channel for industry and between industry and various stakeholders.

The NAPM is the voice of the sector, representing all members equally, at all levels and on all issues.

Members can enjoy the broad networking opportunities with other NAPM members and stakeholders.

International Reach

The NAPM is leveraging its associations such as IGPA and SAGMA to the benefit of our members.

Assisting SAGMA on regulatory issues that will in the long term benefit members with an African strategy.

Informing policy and regulatory issues within SADC to the benefit of our members.

Keeping members updated on the pharmaceutical and regulatory landscape on an African and broader international level.

Generics Education

The NAPM looks at finding innovative and informative ways in which to educate all stakeholders as to the benefits of generic medicine.

Educating the general public on the benefits of using generic medicines.

To grow awareness that generic medicines are really “just as good as” branded medicines – through a proactive Generics Conference in2013.

The promotion of a vibrant generic industry providing greater access to quality medicine.